Apr 17Theolytics successfully closes latest financing raising total of £19M ($24.5M) and welcomes Sound Bioventures as new investor
Oct 6, 2022Theolytics presents CAF-targeting therapy for stromal rich tumours, and strengthens leadership team
May 31, 2022Theolytics' £1M project with InnovateUK to develop a novel therapy for multiple myeloma patients
Sep 21, 2020Theolytics announces appointment of Immatics’ Carsten Reinhardt to its Board of Directors
Jan 7, 2020Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures
